RxDoctor Payments Data

Megan Brady, PA

Physician Assistant · Round Rock, TXNPI 1043991920

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,217, 4.7 times the $678 reported in 2023. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,658in general payments, 2019–2025

Across 356 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$912
  • Lundbeck LLC$680
  • Neurocrine Biosciences, Inc.$679
  • Alkermes, Inc.$654
  • AbbVie$521
  • Axsome Therapeutics, Inc.$472
  • plus $3K from 18 others

What the payments were for

  • Food & beverage$6,658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,658 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Medicare billing

Part B allowed, 2024
$4,980
Medicare patients
24
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate27$1,459
Duloxetine Hcl29$792
Bupropion XlBupropion Hcl47$706
Quetiapine Fumarate12$420
Escitalopram Oxalate30$341
Trazodone Hcl21$278
Alprazolam25$275
Buspirone Hcl17$230
Gabapentin13$189
Fluoxetine Hcl17$105
Lamotrigine11$102
Clonazepam12$51

Paid to pharmacies, not to this prescriber.

Other physician assistant in Round Rock

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →